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Essential oil of star anise as well as phenylpropanoids and sesquiterpenes, for example, trans-anethole, eugenol, β-eudesmol,
farnesol, β-caryophyllene and β-caryophyllene oxide, which are present in many essential oils, were examined for their antiviral
activity against herpes simplex virus type 1 (HSV-1) in vitro. Antiviral activity was analyzed by plaque reduction assays and mode
of antiviral action was determined by addition of the drugs to uninfected cells, to the virus prior to infection or to herpesvirus-
infected cells. Star anise oil reduced viral infectivity by >99%, phenylpropanoids inhibited HSV infectivity by about 60–80% and
sesquiterpenes suppressed herpes virus infection by 40–98%. Both, star anise essential oil and all isolated compounds exhibited
anti-HSV-1 activity by direct inactivation of free virus particles in viral suspension assays. All tested drugs interacted in a dose-
dependent manner with herpesvirus particles, thereby inactivating viral infectivity. Star anise oil, rich in trans-anethole, revealed a
highselectivityindexof160againstHSV,whereasamongtheisolatedcompoundsonlyβ-caryophyllenedisplayedahighselectivity
index of 140. The presence of β-caryophyllene in many essential oils might contribute strongly to their antiviral ability. These
results indicate that phenylpropanoids and sesquiterpenes present in essential oils contribute to their antiviral activity against
HSV.
1.Introduction
Herpes simplex virus type 1 (HSV-1) is an important
pathogen for humans, and discovery of novel eﬀective anti-
herpeticdrugswithoutadverseeﬀectsisofgreatinterest.The
primary symptoms of herpes infection include a prodromal
ﬂu-like syndrome with fever, headache, malaise, diﬀuse
myalgias, followed by local symptoms consisting of itching
and painful papules. Gingivostomatitis and pharyngitis are
the most frequent clinical manifestations of ﬁrst episodes of
HSV-1 infection. After establishing latency, HSV can reacti-
vate, causing frequent recurrent infections in some patients,




compromised patients and neonates, herpetic infections can
cause serious systemic illnesses. Recurrent herpes labialis is
the most frequent clinical manifestation of reactivated HSV-
1 infection.
Av e r ye ﬀective treatment for HSV is available since
the introduction of acyclovir in the 1970s and it is still
the most commonly used chemotherapy [3]. This antiviral
agent can be used to shorten the course and decrease the
severity of these clinical symptoms and may suppress the
virus itself [2]. Antiviral agents licensed currently for the
treatment of herpesvirus infections include acyclovir and
derivatives, foscarnet and cidofovir, all of which inhibit
herpesvirus DNA polymerases [4]. Some of these antiviral
agents might produce toxic side-eﬀects. In addition, the
emergence of virus strains resistant to commonly used
anti-herpesvirus drugs is of importance, particularly in
immunocompromised patients [5–7]. The development of
viral resistance toward antiviral agents enhances the need for
new eﬀective compounds against viral infections. Thus, new
antiviralagentsexhibitingdiﬀerentmechanismsofactionare
urgently needed.
Medicinal plants produce a variety of chemical con-
stituents with the potential to inhibit viral replication and
















Figure 1: Structural formulas of phenylpropanoids and sesquiter-
penes.
sources to control viral infection. These plants have been
widelyusedtotreatavarietyofinfectiousandnon-infectious
diseases and represent an abundant source of new bioactive
secondary metabolites. Thus plants continue to be a major
source of new lead compounds. Besides small molecules
from medicinal chemistry, natural products are still major
sources of innovative therapeutic agents for various condi-
tions, including infectious diseases. In recent years there has
been an increasing interest in the use of natural substances,
and some questions concerning the safety of synthetic
compounds have encouraged more detailed studies of plant
resources. Essential oils, odors and volatile products of
plant secondary metabolism, have a wide application in folk
medicine as well as in fragrance industries. Essential oils are
complex natural mixtures of volatile secondary metabolites,
isolated from plants by hydro- or steam-distillation. The
main constituents of essential oils, for example, monoter-
penes and sesquiterpenes and phenylpropanoids including
carbohydrates, alcohols, ethers, aldehydes and ketones, are
responsible for the fragrant and biological properties of
aromatic and medicinal plants [8]. Various essential oils and
their components possess pharmacological eﬀects, demon-
strating antiinﬂammatory, antioxidant and anticancerogenic
properties [9–11].
Antiherpes screening experiments on medicinal plant
extracts and plant-derived secondary metabolites have been
reported [8, 12]. Antibacterial, antifungal, immunomodu-
latory, antiinﬂammatory and antirheumatic activities have
been described for essential oils [8, 13–21]. The antiherpes
activity of several essential oils of diﬀerent plant sources as
wellasofsomeconstituentsofessentialoilshadbeendemon-
strated previously [22–25]. The application of tea tree oil,
the essential oil of Melaleuca alternifolia, for the treatment
o fr e c u r r e n th e r p e sl a b i a l i sh a sb e e nr e p o r t e dr e c e n t l y[ 26].
The antiherpes activity of eucalyptus oil, Australian tea tree
oil [27], thyme oil [28] and manuka oil [14]h a sp r e v i o u s l y
been published. Other medicinal plant extracts of traditional
Thai medicinal plants showed a pronounced antibacterial
activity against methicillin-resistant Staphylococcus aureus
[29]. Christoph et al. [30, 31]p e r f o r m e dac o m p a r a t i v e
study on the in-vitro antimicrobial activity of tea tree oil
with special reference to the activities of β-triketones. Some
phenylpropanes [32, 33], triterpenes [34] and sesquiterpenes
[35–37] had been tested for their antiviral activity against
diﬀerent herpesviruses and rhinovirus. However, sesquiter-
penes as important constituents of essential oils, have not
been analyzed systematically for their antiviral potential.
Only few reports describe the inhibition of viral replication
by sesquiterpenes, for example, triptofordin C-2 [35]. Thus
only limited information about sesquiterpenes concerning
the inhibition of the viral replication cycle and their mode
o fa n t i v i r a la c t i o ni sp r e s e n t l ya v a i l a b l e .
The aim of the present study is the evaluation of
the antiviral activity of selected sesquiterpenes, important
constituents of essential oils, against HSV-1 and the mode
of antiviral action of these sesquiterpenes during the viral
multiplication cycle.
2. Methods
2.1. Star Anise Oil, Phenylpropanoids, Sesquiterpenes, Acyclo-
vir. Star anise essential oil met the standard demands of
current pharmacopoeias and literature data [38]a n dw a s
obtained from Caelo (Hilden, Germany). This essential
oil is rich in trans-anethole and consists of about 80% of
this phenylpropanoid [39]. Trans-anethole, eugenol, β-
caryophyllene were purchased from Roth GmbH (Karlsruhe,
Germany), and β-eudesmol, farnesol and β-caryophyllene
oxide were purchased from Sigma-Aldrich Chemie GmbH
(Taufkirchen, Germany). All phenylpropanoids and
sesquiterpenes met high purity standards. High contents of
eugenol in clove oil and trans-anethole in star anise oil have
been reported previously [8]. Structural formulas of these
selected phenylpropanoids and sesquiterpenes constituents
are presented in Figure 1. Star anise oil and selected
compounds were dissolved in ethanol and further diluted
in medium for cell culture experiments, always resulting
in an ethanol concentration <1%, which has no eﬀect on
c e l l sa n dv i r u s e s[ 28]. Acyclovir, a commonly used anti-HSV
synthetic drug, was purchased from GlaxoSmithKline (Bad
Oldesloe, Germany), dissolved in sterile water and applied as
reference compound.
2.2. Cell Culture and HSV-1. RC-37 cells (African green
monkey kidney cells) were grown in monolayer culture
with Dulbecco’s modiﬁed Eagle’s medium (DMEM; Gibco,
Karlsruhe, Germany) supplemented with 5% fetal calf serum
(FCS; Gibco, Karlruhe, Germany), 100UmL−1 penicillin
and 100μgmL −1 streptomycin (both Gibco, Karlsruhe,
Germany). The monolayers were removed from their
plastic surfaces and serially passaged whenever they becameEvidence-Based Complementary and Alternative Medicine 3
conﬂuent. Cells were plated onto 96-well and 6-well culture
plates for cytotoxicity and antiviral assays, respectively, and
propagated at 37◦Ci na na t m o s p h e r eo f5 %C O 2.H S V - 1
strain KOS was used for all experiments. Viruses were
routinely grown on RC-37 cells and virus stock cultures
were prepared from supernatants of infected cells and stored
at −80◦C. Infectivity titers were determined by a standard
plaque assay on conﬂuent RC-37 cells [40].
2.3. Cytotoxicity Assay. The eﬀect of star anise oil, phenyl-
propanoids and sesquiterpenes on the proliferation of RC-
37 cells was determined in 96-well tissue culture plates at
an initial density of 1 × 105 cells mL−1. For cytotoxicity
assays, cells were seeded onto 96-well plates and incubated
for 24h at 37◦C. The medium was removed and fresh
DMEM containing the appropriate dilution of the essential
oil or compounds was added onto subconﬂuent cells in
eight replicates for each concentration of the drugs. Wells
containing medium with 1% ethanol but no drug were also
includedoneachplateascontrols.After3daysofincubation,
the growth medium was removed and viability of the drug-
treated cells was determined in a standard neutral red assay
[41]. Neutral red dye uptake was determined by measuring
the optical density (OD) of the eluted neutral red at 540
nm in a spectrophotometer. The mean OD of the cell-
control wells was assigned a value of 100%. The cytotoxic
concentration of the drug that reduced viable cell number
by 50% (TC50) was determined from dose-response curves.
Additionally the maximum noncytotoxic concentration of
each drug was determined.
2.4. Dose-Response Assays. The antiviral activity of star
anise oil, phenylpropanoids and sesquiterpenes was assayed
by plaque reduction assay. A virus suspension of HSV-1
containing 2 × 103 plaque forming units (pfumL−1)w a s
incubated with an equal volume of DMEM or various
concentrations of star anise oil or phenylpropanoids and
sesquiterpenes for 1h at room-temperature, then virus
was allowed to adsorb to the cells for 1h at 37◦C. The
residual inoculum was replaced by medium containing
0.5% methylcellulose. After incubation for 3 days at 37◦C,
monolayers were ﬁxed with 10% formalin. The cultures were
stained with 1% crystal violet and subsequently the plaques
were counted. Each concentration was performed in three
replicates, virus-infected cells in wells containing medium
with1%ethanolbutnodrugwerealsoincludedoneachplate
as controls. Inhibitory concentration (IC50) was expressed as
antiviral activity, which inhibited plaque numbers by 50%
compared with untreated control and was determined from
dose-response curves.
2.5. Time of Addition Studies. Star anise oil, phenyl-
propanoids or sesquiterpenes were added to the cells before,
during and after virus infection. The maximum noncyto-
toxic concentration was always used to evaluate the mode
of antiviral action. Cell monolayers were pretreated with
drugs prior to inoculation with virus by adding the oil
or compounds to the medium followed by incubation for
































































Figure 2: Antiviral activity of serial dilutions of (a) star anise
oil, phenylpropanoids and (b) sesquiterpenes against HSV-1 in
viral suspension assays. Diluted drugs were tested up to the
maximum noncytotoxic concentration. Number of virus plaques
was determined 3 days after infection and compared to untreated
control. Results are presented as percentage of plaque reduction,
experiments were repeated independently and data are the mean of
three experiments ± SD.
2 × 103 pfu of HSV were incubated in medium containing
the drugs for 1h at room-temperature prior to infection
of RC-37 cells. The eﬀect of essential oil or components
against HSV was also tested during the replication period by
addition of drugs after cell infection to the overlay medium,
as typically performed in antiviral susceptibility studies.
Each assay was run in three replicates. Plaque reduction
assays were carried out as described above and number of
plaques of drug-treated cells and viruses were compared
with untreated controls. Wells containing medium with 1%
ethanol but no drug were also included on each plate as
controls.
2.6. Statistical Analysis. The selectivity index (SI) was deter-
mined by the ratio of TC50 to IC50. All experiments were
performed in triplicate, and three independent experiments
were conducted. Data were presented as mean ± SD and4 Evidence-Based Complementary and Alternative Medicine
Table 1: Selectivity indices of anise oil and selected phenylpropanoids and sesquiterpenes against HSV-1(a).
Essential oil/compound Max. non-cytotoxic conc.
(μgmL −1) ± SD
TC50 (μgmL −1) ± SD IC50 (μgmL −1) ± SD SI
Star anise oil 100 ± 8.0 160 ± 30.7 1 ± 0.1 160
Trans-anethole 70 ± 3.0 100 ± 6.4 20 ± 1.1 5
Eugenol 60 ± 11.1 85 ± 8.1 35 ± 6.2 2.4
β-Eudesmol 9 ± 1.3 35 ± 5.4 6 ± 0.3 5.8
Farnesol 10 ± 0.4 40 ± 3.7 3.5 ± 0.1 11.4
β-Caryophyllene 10 ± 0.1 35 ± 2.3 0.25 ± 0.0 140
β-Caryophyllene oxide 9 ± 1.1 18 ± 1.2 0.7 ± 0.1 25.7
(a)Experiments were repeated independently and data presented are the mean of three experiments.
t-test was used to evaluate the diﬀerence between the test
and control. A P-value of < .05 was considered statistically
signiﬁcant.
3. Results
3.1. Cytotoxicity of Essential Oil Compounds. Star anise
oil and six selected phenylpropanoids and sesquiterpenes
(Figure 1) were serially diluted in ethanol and added to
cell culture medium to examine the eﬀect on the growth
and viability of tissue culture cells, always resulting in an
ethanol concentration <1%, which had no eﬀect on cells and
viruses. After 3 days of incubation, cell viability of RC-37
cells was determined with the neutral red assay (Table 1).
The maximum noncytotoxic concentrations of these drugs
were determined between 9μgmL −1 for β-caryophyllene
oxide and β-eudesmol and 100μgmL −1 for star anise oil, the
drug which revealed the lowest cytotoxicity. Similar results
were found for TC50 values, for example, 18μgmL −1 for β-
caryophyllene oxide and 160μgmL −1 for star anise oil.
3.2. Antiviral Activity of Essential Oil Compounds. The
potential antiviral eﬀect of star anise essential oil and
some selected components from diﬀerent essential oils was
determined against HSV-1 in vitro. HSV-1 was incubated
for 1h at room-temperature with various concentrations
of star anise oil, trans-anethole, eugenol, β-eudesmol, far-
nesol, β-caryophyllene and β-caryophyllene oxide. In all
assays untreated virus-infected cells were used as a control.
Subsequently, aliquots of each dilution were incubated
with RC-37 cells for 1h, then the cells were washed and
overlaid with drug-free medium and incubated for 3 days at
37◦C. The 50% inhibitory concentrations (IC50)f o rH S V -
1 were determined in a wide range between 0.25μgmL −1
for β-caryophylle and 35μgmL −1 for eugenol (Table 1).
The results are presented in Figures 2(a) and 2(b) as virus
reduction and represent the average of three independent
experiments. In plaque reduction assays, star anise oil and
compounds exhibited a concentration-dependent antiviral
eﬀect, star anise oil with a SI of 160 was the most eﬀective
drug and slightly superior to β-caryophyllene with a SI of
140. SIs for tested drugs against HSV were calculated as the
TC50/IC50 ratio. The essential oil of star anise was able to
suppress viral multiplication by >99% (Figure 2(a)). Out of
six tested compounds, only trans-anethole, β-caryophyllene
and farnesol suppressed herpesvirus infectivity by >90% at
the maximum noncytotoxic concentration of these drugs.
3.3. Mechanism of Antiviral Action. For investigation of the
inhibitory eﬀect on HSV in detail, all drugs were added
at diﬀerent stages during viral infection. For comparison,
all untreated controls contained the same concentration of
ethanol as the drug-treated viruses, in order to exclude any
inﬂuence of ethanol. When host cells were pretreated with
drugs prior to infection, none of the tested drugs showed
statistically signiﬁcant eﬀects (P = 0.2–0.4) on viral infection
(Figure 3(a)). On the other hand, pretreatment of HSV-1
with star anise oil, phenylpropanoids or sesquiterpenes prior
to infection inhibited herpesvirus infectivity. At maximum
noncytotoxic concentrations of the tested drugs, infectiv-
ity was reduced by >99% for star anise oil followed by
98% reduction for β-caryophyllene (Figure 3(b)). All other
constituents of essential oils revealed a plaque reduction of
HSV between about 60 and 90%. However, the antiviral
eﬀect of eugenol was not statistically signiﬁcant (P = .07).
Acyclovir showed the highest antiviral activity when added
during the replication period with inhibition of the viral
replication of >99% (data not shown). This drug inhibits
speciﬁcally the viral DNA polymerase during the replication
cycle when new viral DNA is synthesized. In contrast,
when the oil or compounds were added to the overlay
medium after penetration of the viruses into the host cells,
plaque formation was not signiﬁcantly (P = 0.2–0.4) reduced
(Figure 2.6).
4. Discussion
The pharmaceuticalindustry is increasingly targeting medic-
inal plants with the aim of identifying lead compounds,
focusing particularly on suitable alternative antiviral agents.
Topical treatment of herpes labialis infection is standard, for
the most part carried out not only with acyclovir creams, but
also with phytopharmaceuticals containing sage or lemon
balm extracts [42–44]. Both plant extracts were shown
to be signiﬁcantly superior to placebo and equivalent to
acyclovir [43]. Our previous in-vitro experiments revealed
similar results for essential oils from eucalyptus, tea tree



































































































































































































































































































































































































Figure 3: Antiviral activity of star anise essential oil and diﬀerent compounds of essential oils against HSV in time of addition assays. (a)
Pretreatment of cells with drugs, (b) pretreatment of virus with drugs and (c) addition of drugs during intracellular replication of HSV.
Number of virus plaques was determined 3 days after infection and compared to untreated control. Results are presented as percentage of
plaque reduction and are the mean of three independent experiments ± SD and statistically signiﬁcant results are marked with asterisk.
inhibitory eﬀect of star anise oil against HSV infection was
compared with the antiviral potential of phenylpropanoid
and sesquiterpene compounds. Experiments to assess the
cytotoxicity of essential oils and monoterpenes for cultured
eukaryotic cells indicate a moderate toxic behavior in cell
cultures according to Halle and G¨ ores [47]. Star anise
essential oil and most compounds exhibited high levels of
antiviral activity against HSV-1 in viral suspension tests.
At maximum noncytotoxic concentrations plaque formation
was signiﬁcantly reduced by >99% for star anise oil, phenyl-
propanoids and sesquiterpenes were able to suppress viral
infection by 60–80% and 40–98%, respectively.
The mode of antiviral action was determined in time of
addition assays. Pretreatment of the cells with these drugs
had no eﬀect on the production of infectious virus and
plaque formation. The same results were found when star
anise oil or compounds were added during the replication











Star anise oil, phenylpropanoids
and sesquiterpenes interact with
free virus particles prior to cell
attachment
Figure 4: Star anise oil, phenylpropanoids and sesquiterpenes
exhibited antiviral activity by direct interaction with free virus
particles. Pretreatment of cells with the drugs had no eﬀect on viral
infectivity, neither during intracellular viral replication.
was observed for star anise oil, trans-anethole, farnesol and
β-caryophyllene when herpesvirus was incubated with these
drugs prior to host cell infection (Figure 4). These results
suggest that these drugs directly inactivate herpes virus and
might interfere with virion envelope structures or mask
viral structures that are necessary for adsorption or entry
into host cells. A virucidal activity of Melaleuca armillaris
essential oil has been reported recently [27] and dissolution
of the HSV envelope by treatment with oregano essential
oil has been described [48]. Thus diﬀerent mechanisms of
antiviral activity of diﬀerent essential oils and compounds of
essential oils seem to be present. De Logu et al. [12]r e p o r t e d
an inactivation of herpesviruses and prevention of cell-to-
cell spread by Santolina insularis essential oil. However, no
antiviral eﬀect was observed during the intracellular replica-
tion phase, which is in accordance to our results and other
essential oils [46]. Adenovirus, a virus without envelope, was
not aﬀected by eucalyptus essential oil due to the lack of a
viralenvelope[21].Sesquiterpenes,forexample,triptofordin
C-2 and sesquiterpene coumarins inhibit cytomegalovirus
[35],severeacuterespiratorysyndromecoronavirus[49]and
rhinovirus [37]. Pusztai et al. [36] reported a speciﬁc inhibi-
tion of the CMV immediate early gene expression, whereas
other sesquiterpenes are moderately virucidal against diﬀer-
ent enveloped viruses, for example, HSV, cytomegalovirus,
measles virus and inﬂuenza virus [35]. Eugenol, a phenyl-
propane that represents about 75% v/v in clove essential oil,
delayed the development of herpesvirus-induced keratitis in
the mouse model [32] and inactivated HSV directly [39].
Direct inactivation of virus particles by eugenol represents
the same antiviral mechanism as examined for the con-
stituents in this study. Isoborneol, a monoterpene and a
component of several plant essential oils, showed virucidal
activity against HSV-1 and speciﬁcally inhibited glycosyla-
tionofviralproteins[50].Theapplicationofcineoleprotects
mice against infection with HSV-2 [22]. Since essential oils
are able to inhibit acyclovir-resistant HSV-1 isolates [28],
the mechanism of interaction between these compounds
and acyclovir with HSV must be diﬀerent. Acyclovir inhibits
virus replication by interference with the DNA polymerase
inside the cell, whereas star anise oil, phenylpropanoids
and sesquiterpenes probably inactivate HSV before it enters
the cell. Viral resistance to acyclovir represents a particular
problem, the prevalence of resistance in acyclovir-treated
immunocompromisedindividualsis ∼4–7%[51,52].There-
fore other antiherpetic agents that are eﬀective for viral
mutants resistant to current antiviral agents are of great
interest for topical treatment. The application of tea tree oil,
the essential oil of Melaleuca alternifolia, for the treatment of
recurrent herpes labialis has been reported recently [26, 53].
Thecomplexmixtureoftheessentialoilrevealedahigher
antiviral activity and SI of 160, whereas single constituents
revealed lower selectivity indices. However β-caryophyllene
revealed a SI of 140, which is in the same range as the
index value of 160 for star anise oil and is found in many
diﬀerent essential oils from diﬀerent plant families. Thus
β-caryophyllene might be one of the dominant antiviral
agents in diﬀerent essential oils. The antiviral potential of
t h et e s tc o m p o u n d si no u rs t u d yc a nb et r a c e db a c kt o
their structural features. The sesquiterpene hydrocarbon
β-caryophyllene is the most active antiviral compound
with an IC50 of 0.25μgmL −1. The introduction of either
an epoxide or hydroxyl function into the sesquiterpene
backbone led to a moderate decrease in its antiviral eﬀect.
Cos et al. [54] recommended IC50 values for promising
natural products against infectious diseases, for example, for
extracts <100μgmL −1. Star anise essential oil in our study
revealed an IC50 values of 1μgmL −1 and is far below the
recommended cutoﬀ and presents a promising antiinfective
agent according to this recommendation.
In conclusion, medicinal and aromatic plants are widely
used today in modern phytotherapy [55]. The essential
oils and their components are known to be active against
a wide variety of microorganisms [56]. Phenylpropanoids
and sesquiterpenes present in essential oils contribute to
their antiviral activity. Drugs with a high SI are preferable
for antiviral treatment in patients, thus star anise oil as a
complex mixture and β-caryophyllene as single constituent
might be applied as topical therapeutic agents in the
treatment of recurrent herpes infection.
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